Hunterscreek.net - TAVR-30 App | Identify Patients at Increased Risk of 30

Provided by Alexa ranking, hunterscreek.net has ranked N/A in N/A and 2,537,074 on the world. hunterscreek.net reaches roughly 1,225 users per day and delivers about 36,761 users each month. The domain hunterscreek.net uses a Commercial suffix and it's server(s) are located in N/A with the IP number 173.242.31.11 and it is a .net domain.

About TAVR-30 TM. Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has …

List of domain same IP 173.242.31.11

Search Results related to hunterscreek.net on Search Engine

TAVR-30 App | Identify Patients at Increased Risk of 30
tavr30.com

https://tavr30.com/

About TAVR-30 TM. Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has …

DA: 54 PA: 44 MOZ Rank: 5

Current Initiatives - TAVR-30 App - Make A Dent
makeadent.org

https://makeadent.org/initiatives/tavr-30-app/

TAVR-30 App Identify TAVR patients at increased risk of 30-day readmission. Aid in appropriate transition of care upon discharge and post-discharge follow-up. Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced ...

DA: 22 PA: 33 MOZ Rank: 60

‎TAVR-30 on the App Store
apple.com

https://apps.apple.com/us/app/tavr-30/id1424785673

Sep 22, 2018 . Download TAVR-30 and enjoy it on your iPhone, iPad, and iPod touch. ‎Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has been reported at 15-20%.

DA: 32 PA: 29 MOZ Rank: 32

Transcatheter Aortic Valve Replacement | CMS
cms.gov

https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/TAVR

May 01, 2012 . Transcatheter aortic valve replacement (TAVR - also known as TAVI or transcatheter aortic valve implantation) is a new technology for use in treating aortic stenosis. A bioprosthetic valve is inserted percutaneously using a catheter and implanted in the orifice of the native aortic valve.

DA: 51 PA: 18 MOZ Rank: 33

Data Collection - NCDR
ncdr.com

https://www.ncdr.com/WebNCDR/tvt/publicpage/data-collection

The STS/ACC TVT Registry TM delivers insight into practice patterns and patient outcomes for your transcatheter valve replacement and repair procedures.. The STS/ACC TVT Registry™ measures: Patient demographics, provider and facility characteristics ; History/risk factors, cardiac status and detailed health status

DA: 28 PA: 18 MOZ Rank: 74

Edwards TAVR | Less Invasive Therapy for Severe Aortic
edwards.com

https://tavrbyedwards.edwards.com/

TAVR can be considered for more patients than ever before. Only a Heart Team can determine if you're right for TAVR, but today any severe aortic stenosis patient can be considered. Known as the less invasive option, Edwards TAVR puts quality of life first and has changed the way severe aortic stenosis is treated. Learn More.

DA: 97 PA: 24 MOZ Rank: 32

Medtronic self-expanding TAVR platform shows excellent
businessinsider.com

https://markets.businessinsider.com/news/stocks/medtronic-self-expanding-tavr-platform-shows-excellent-longer-term-performance-at-five-years-in-surtavi-trial-1030943058

Nov 05, 2021 . At five years, rates of all-cause mortality were similar between TAVR with the CoreValve/Evolut platform and surgical aortic valve replacement (SAVR) (30.0% for TAVR versus 28.7% for SAVR; p=0.55 ...

DA: 44 PA: 62 MOZ Rank: 35

TAVR with SAPIEN 3 Demonstrated as Economically …
prnewswire.com

https://www.prnewswire.com/news-releases/tavr-with-sapien-3-demonstrated-as-economically-dominant-treatment-strategy-compared-to-surgery-in-partner-3-analysis-301417648.html

Nov 05, 2021 . "TAVR is a unique technology with advantages over surgery from the perspective of both the patient and the healthcare system." The PARTNER 3 trial randomized 1,000 patients at …

DA: 31 PA: 65 MOZ Rank: 7

TAVR Chugging Along at 5 Years in SURTAVI Trial | …
medpagetoday.com

https://www.medpagetoday.com/meetingcoverage/tct/95489

Nov 06, 2021 . TAVR outperformed surgery with respect to core lab-assessed hemodynamics. However, it was associated with more paravalvular leak (30.1% …

DA: 62 PA: 69 MOZ Rank: 17

Best Hospitals for Transcatheter Aortic Valve Replacement
usnews.com

https://health.usnews.com/best-hospitals/hospital-ratings/transcatheter-aortic-valve-replacement

Compare hospital ratings for Transcatheter Aortic Valve Replacement (TAVR). TAVR is a relatively new procedure performed to improve blood flow to the heart for those patients with a narrow aortic ...

DA: 83 PA: 17 MOZ Rank: 69

OpSens Successfully Completes 20-Patient in Human Clinical
finanzen.net

https://www.finanzen.net/nachricht/aktien/opsens-successfully-completes-20-patient-in-human-clinical-study-for-tavr-procedure-10775571

Nov 23, 2021 . Login. Favoriten mehr Infos ... TAVR market outlook for procedural growth remains highly attractive globally ... The OptoWire has been used in the diagnosis and …

DA: 9 PA: 15 MOZ Rank: 3

TAVR with SAPIEN 3 Demonstrated as Economically Dominant
advfn.com

https://ih.advfn.com/stock-market/NYSE/edwards-lifesciences-EW/stock-news/86479259/tavr-with-sapien-3-demonstrated-as-economically-do

Nov 05, 2021 . "TAVR is a unique technology with advantages over surgery from the perspective of both the patient and the healthcare system." The PARTNER 3 trial randomized 1,000 patients at 71 centers between March 2016 and October 2017. Patients were assigned to undergo either TAVR with the SAPIEN 3 valve or surgery with any commercially available surgical ...

DA: 85 PA: 63 MOZ Rank: 17

Medtronic Touts 5-Year Data Of Self-Expanding TAVR Platform
benzinga.com

https://www.benzinga.com/news/21/11/23927282/medtronic-touts-5-year-data-of-self-expanding-tavr-platform

Nov 05, 2021 . Additionally, valve thrombosis remained low out to five years for both TAVR and SAVR. Price Action: MDT shares are up 2.30% at $123.47 during the market session on the last check Friday.

DA: 64 PA: 90 MOZ Rank: 23

Medtronic self-expanding TAVR platform shows excellent
advfn.com

https://ih.advfn.com/stock-market/NYSE/medtronic-MDT/stock-news/86479065/medtronic-self-expanding-tavr-platform-shows-excel

Nov 05, 2021 . At five years, rates of all-cause mortality were similar between TAVR with the CoreValve/Evolut platform and surgical aortic valve replacement (SAVR) (30.0% for TAVR versus 28.7% for SAVR; p=0.55), while rates of disabling stroke were also similar (4.1% for TAVR versus 5.8% for SAVR, p = 0.12).

DA: 90 PA: 4 MOZ Rank: 36

Closure systems for TAVR procedures vary by complications
healio.com

https://www.healio.com/news/cardiac-vascular-intervention/20211112/closure-systems-for-tavr-procedures-vary-by-complications-time-to-hemostasis

Nov 12, 2021 . Closure systems for TAVR procedures vary by complications, time to hemostasis. Abdel-Wahab M, et al. Late-Breaking Clinical Trials Session II, in Collaboration with JAMA. Presented at: TCT ...

DA: 78 PA: 17 MOZ Rank: 85

Transcatheter Aortic Valve Replacement | NHLBI, NIH
nih.gov

https://www.nhlbi.nih.gov/health-topics/tavr

Transcatheter aortic valve replacement (TAVR) is a procedure to treat aortic stenosis, a type of heart valve disease. TAVR replaces a faulty aortic valve with an aortic valve made from animal tissue. The TAVR procedure does not require open-heart surgery. The aortic valve is one of four valves that control blood flow in the heart. The aortic ...

DA: 16 PA: 91 MOZ Rank: 29

Cerebral Embolic Protection and the Low Risk TAVR Patient
vumedi.com

https://www.vumedi.com/video/cerebral-embolic-protection-and-the-low-risk-tavr-patient/

Oct 28, 2021 . As TAVR is used on more patients with low and intermediate risk, we have seen that unfortunately, even with newer technology and implant techniques, stroke does persist. In this product workshop, Drs. James E. Harvey and Suzanne J. Baron review the data around stroke incidence in TAVR, the impact and cost it can have on patients and hospitals, and how cerebral protection can …

DA: 35 PA: 86 MOZ Rank: 81

2019 TAVR Billing & Coding Guide - Boston Scientific
bostonscientific.com

https://www.bostonscientific.com/content/dam/bostonscientific/StructuralHeart/lotus-edge/administrator-resources/TAVR%20Billing%20and%20Coding%20Guide%20(IC-580403-AB).pdf

$1,663 30.00 Aortic 46.14 33365 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transaortic approach (e.g., median sternotomy, mediastinotomy) $1,868 33.12 Aortic 51.83 33366 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (eg, left thoracotomy) $2,019 35.88 Aortic 56.03

DA: 90 PA: 53 MOZ Rank: 62

Hospital Variation in 30‐Day Readmissions Following
ahajournals.org

https://www.ahajournals.org/doi/10.1161/JAHA.120.021350

May 03, 2021 . Thirty‐day all‐cause readmission rates after TAVR have ranged from 16.0% to 20.9% in previous studies. 3, 4, 5 Technological advancement, increased operator experience, and decrease in patient risk profile have resulted in substantial improvements in TAVR outcomes over the past several years, including a decline in 30‐day readmission ...

DA: 20 PA: 75 MOZ Rank: 18

Alexa Rank

GLOBAL RANK

2,537,074

Alexa Reach

0.0000540923

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

1,225

Monthly Unique Visitors

36,761

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

7,863

Indonesia

6,150

Taiwan

2,000

United Kingdom

1,776

Brazil

1,606

Nigeria

1,404

Egypt

1,180

Hong Kong

1,114

Canada

1,114

Australia

970

Philippines

695

India

676

Malaysia

665

Spain

551

Germany

537

Mexico

515

France

485

Italy

448

Turkey

412

Iraq

375

Thailand

368

Netherlands

353

Israel

349

Cambodia

290

Algeria

224

Ireland

202

Romania

195

Jordan

180

Poland

173

Ghana

165

Argentina

158

South Africa

143

Belgium

129

Czechia

118

Ukraine

110

Japan

110

Morocco

107

South Korea

103

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa Statistics Graph for hunterscreek.net

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
hunterscreek.net	HINFO	IN	3789	Cpu: RFC8482 Os:

Hosting and Whois Zone

IP	173.242.31.11
Domain infomation	Domain Name: HUNTERSCREEK.NET Registry Domain ID: 23685491_DOMAIN_NET-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2024-02-15T14:47:35Z Creation Date: 2000-03-29T21:09:36Z Registry Expiry Date: 2027-03-29T20:09:35Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS45.WORLDNIC.COM Name Server: NS46.WORLDNIC.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of whois database: 2025-03-18T12:50:53Z <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars.

Hunterscreek.net - TAVR-30 App | Identify Patients at Increased Risk of 30

Keywords on this domain

hunters creek